Keywords: novartis, tasigna, gets, eu, approval, swiss, drug

Novartis' Tasigna gets EU approval

Article | 03 December 2007

Print This

Swiss drug major Novartis says that Tasigna (nilotinib) has received European Union approval as a new anticancer therapy for patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in